Total Funding: 51447828.0
Headquarters: Seattle, Washington, United States
Funding Status: Early Stage Venture
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Last Funding Type: Series B
Technology: Biotechnology, Information Services, Information Technology, Manufacturing
Last Funding Date: 2022-03-29
Investors Number: 13.0
Founded Date: 2008-01-01
Industry: Early Drug Development